Characterization of synaptic dysfunction in an in vitro corticostriatal model system of Huntington's disease

被引:1
|
作者
Artamonov D.N. [1 ]
Korzhova V.V. [1 ]
Wu J. [2 ]
Rybalchenko P.D. [1 ]
Im K. [2 ]
Krasnoborova V.A. [1 ]
Vlasova O.L. [1 ]
Bezprozvanny I.B. [1 ,2 ]
机构
[1] Laboratory of Molecular Neurodegeneration, St. Petersburg Polytechnic University, St. Petersburg 195251, ul. Politekhnicheskaya
[2] Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX 75390
关键词
dendritic spines; Huntington's disease; neuronal culture; optogenetics; synaptic transmission;
D O I
10.1134/S1990747813040028
中图分类号
学科分类号
摘要
Huntington's disease (HD) is an autosomal-dominant inherited neurodegenerative disease resulting from expanded amino acid (CAG) repeat in the gene that encodes protein huntingtin (Htt). HD remains incurable for now. A lot of evidence implicates aberrant synaptic connection between cortical and striatal neurons, a key component of HD pathophysilogy, which also leads to cognitive decline and motor disorders. In the present work synaptic activity between cortical and striatal neurons was studied on the corticostriatal co-culture model system of HD. Culture was prepared from HD mouse model YAC128. It was shown that first impairment appears on day 14 in vitro. Interestingly, these alterations occur in cortical neurons. Their activity in YAC128 cultures was higher than in cultures of wild-type neurons. At the same time, there were no differences in morphology of spines in striatal neurons. However, using novel optogenetic approach, we demonstrated that synaptic connections are already dysfunctional in YAC128 cultures. On day 19 in vitro the activity of cortical neurons in YAC128 cultures was reduced, which led to alterations on the post-synaptic side. Dendric spines of medium spiny neurons transformed and disappeared, which is possibly the main reason of neurodegenerative mechanisms during the HD development. © 2013 Pleiades Publishing, Ltd.
引用
收藏
页码:192 / 202
页数:10
相关论文
共 50 条
  • [21] Auditory dysfunction in patients with Huntington's disease
    Profant, Oliver
    Roth, Jan
    Bures, Zbynek
    Balogova, Zuzana
    Liskova, Irena
    Betka, Jan
    Syka, Josef
    CLINICAL NEUROPHYSIOLOGY, 2017, 128 (10) : 1946 - 1953
  • [22] Striosomes and mood dysfunction in Huntington's disease
    Tippett, Lynette J.
    Waldvogel, Henry J.
    Thomas, Sally J.
    Hogg, Virginia M.
    van Roon-Mom, Willeke
    Synek, Beth J.
    Graybiel, Ann M.
    Faull, Richard L. M.
    BRAIN, 2007, 130 : 206 - 221
  • [23] Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice
    Deng, Y. P.
    Wong, T.
    Bricker-Anthony, C.
    Deng, B.
    Reiner, A.
    NEUROBIOLOGY OF DISEASE, 2013, 60 : 89 - 107
  • [24] Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease
    Renoir, Thibault
    Argyropoulos, Andrew
    Chevarin, Caroline
    Lanfumey, Laurence
    Hannan, Anthony J.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 127 : 15 - 20
  • [25] CHARACTERIZATION OF ADENINE NUCLEOTIDE METABOLISM IN CELLULAR MODEL OF HUNTINGTON'S DISEASE
    Toczek, M.
    Pierzynowska, K.
    Kutryb-Zajac, B.
    Gaffke, L.
    Slominska, E. M.
    Wegrzyn, G.
    Smolenski, R. T.
    PURINERGIC SIGNALLING, 2018, 14 : S81 - S81
  • [26] Characterization of adenine nucleotide metabolism in the cellular model of Huntington's disease
    Toczek, Marta
    Pierzynowska, Karolina
    Kutryb-Zajac, Barbara-
    Gaffke, Lidia
    Slominska, Ewa M.
    Wegrzyn, Grzegorz
    Smolenski, Ryszard T.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2018, 37 (11) : 630 - 638
  • [27] Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction
    Smith, R
    Petersén, Å
    Bates, GP
    Brundin, P
    Li, JY
    NEUROBIOLOGY OF DISEASE, 2005, 20 (03) : 673 - 684
  • [28] Neurotrophin-3 restores synaptic plasticity in the striatum of a mouse model of Huntington's disease
    Gomez-Pineda, Victor G.
    Torres-Cruz, Francisco M.
    Vivar-Cortes, Cesar I.
    Hernandez-Echeagaray, Elizabeth
    CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (04) : 353 - 363
  • [29] Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease
    Morton, AJ
    Faull, RLM
    Edwardson, JM
    BRAIN RESEARCH BULLETIN, 2001, 56 (02) : 111 - 117
  • [30] In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system
    Bari, Monica
    Battista, Natalia
    Valenza, Marta
    Mastrangelo, Nicolina
    Malaponti, Marinella
    Catanzaro, Giuseppina
    Centonze, Diego
    Finazzi-Agro, Alessandro
    Cattaneo, Elena
    Maccarrone, Mauro
    FEBS JOURNAL, 2013, 280 (14) : 3376 - 3388